TW205095B - - Google Patents

Download PDF

Info

Publication number: TW205095B
Authority: TW; Taiwan
Prior art keywords: antigen; antibody; analysis; hiv; compound
Prior art date: 1990-11-09

Application number

TW080109188A

Other languages

English (en)

Chinese (zh)

Inventor

Peggy L Guidinger

Bryan C Peterson

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-09

Filing date

1991-11-22

Publication date

1993-05-01

1991-11-22 Application filed by Abbott Lab filed Critical Abbott Lab

1993-05-01 Application granted granted Critical

1993-05-01 Publication of TW205095B publication Critical patent/TW205095B/zh

Links

239000000427 antigen Substances 0.000 claims description 45
108091007433 antigens Proteins 0.000 claims description 44
102000036639 antigens Human genes 0.000 claims description 44
239000000523 sample Substances 0.000 claims description 43
238000004458 analytical method Methods 0.000 claims description 37
150000001875 compounds Chemical class 0.000 claims description 36
230000009870 specific binding Effects 0.000 claims description 29
239000002245 particle Substances 0.000 claims description 26
239000000126 substance Substances 0.000 claims description 26
239000007790 solid phase Substances 0.000 claims description 24
-1 acridine sulfonamide compound Chemical class 0.000 claims description 23
238000009739 binding Methods 0.000 claims description 23
239000000203 mixture Substances 0.000 claims description 22
230000027455 binding Effects 0.000 claims description 21
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
238000003018 immunoassay Methods 0.000 claims description 20
238000000034 method Methods 0.000 claims description 20
238000012360 testing method Methods 0.000 claims description 20
239000012528 membrane Substances 0.000 claims description 18
239000003623 enhancer Substances 0.000 claims description 17
DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 14
238000006243 chemical reaction Methods 0.000 claims description 14
239000003153 chemical reaction reagent Substances 0.000 claims description 14
229960002685 biotin Drugs 0.000 claims description 11
239000011616 biotin Substances 0.000 claims description 11
235000020958 biotin Nutrition 0.000 claims description 10
238000005406 washing Methods 0.000 claims description 8
108090001008 Avidin Proteins 0.000 claims description 7
241000714260 Human T-lymphotropic virus 1 Species 0.000 claims description 6
239000011859 microparticle Substances 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 5
230000035945 sensitivity Effects 0.000 claims description 5
230000001745 anti-biotin effect Effects 0.000 claims description 4
238000001514 detection method Methods 0.000 claims description 4
239000011541 reaction mixture Substances 0.000 claims description 4
239000006166 lysate Substances 0.000 claims description 3
241000700605 Viruses Species 0.000 claims description 2
239000011324 bead Substances 0.000 claims description 2
210000004369 blood Anatomy 0.000 claims description 2
239000008280 blood Substances 0.000 claims description 2
239000011521 glass Substances 0.000 claims description 2
210000002966 serum Anatomy 0.000 claims description 2
208000031886 HIV Infections Diseases 0.000 claims 4
241000713340 Human immunodeficiency virus 2 Species 0.000 claims 4
241000725303 Human immunodeficiency virus Species 0.000 claims 3
238000003556 assay Methods 0.000 claims 3
241000713772 Human immunodeficiency virus 1 Species 0.000 claims 2
108010032595 Antibody Binding Sites Proteins 0.000 claims 1
101710132601 Capsid protein Proteins 0.000 claims 1
241000700721 Hepatitis B virus Species 0.000 claims 1
241000598436 Human T-cell lymphotropic virus Species 0.000 claims 1
239000003463 adsorbent Substances 0.000 claims 1
230000004520 agglutination Effects 0.000 claims 1
230000003321 amplification Effects 0.000 claims 1
238000002038 chemiluminescence detection Methods 0.000 claims 1
238000000605 extraction Methods 0.000 claims 1
208000002672 hepatitis B Diseases 0.000 claims 1
238000003199 nucleic acid amplification method Methods 0.000 claims 1
238000012216 screening Methods 0.000 claims 1
239000009916 yin-huang Substances 0.000 claims 1
239000012491 analyte Substances 0.000 description 34
239000000243 solution Substances 0.000 description 29
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 22
238000011049 filling Methods 0.000 description 13
239000007787 solid Substances 0.000 description 13
239000007853 buffer solution Substances 0.000 description 11
239000004816 latex Substances 0.000 description 11
229920000126 latex Polymers 0.000 description 11
239000000725 suspension Substances 0.000 description 11
239000004793 Polystyrene Substances 0.000 description 10
229920002223 polystyrene Polymers 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
241000711549 Hepacivirus C Species 0.000 description 8
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 8
239000000463 material Substances 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
108091003079 Bovine Serum Albumin Proteins 0.000 description 6
229940098773 bovine serum albumin Drugs 0.000 description 6
YFVGRULMIQXYNE-UHFFFAOYSA-M lithium;dodecyl sulfate Chemical compound [Li+].CCCCCCCCCCCCOS([O-])(=O)=O YFVGRULMIQXYNE-UHFFFAOYSA-M 0.000 description 6
239000011734 sodium Substances 0.000 description 6
229920001213 Polysorbate 20 Polymers 0.000 description 5
ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical group C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 5
239000007788 liquid Substances 0.000 description 5
150000002978 peroxides Chemical class 0.000 description 5
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
229910052708 sodium Inorganic materials 0.000 description 5
OIXUJRCCNNHWFI-UHFFFAOYSA-N 1,2-dioxane Chemical compound C1CCOOC1 OIXUJRCCNNHWFI-UHFFFAOYSA-N 0.000 description 4
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
150000001251 acridines Chemical class 0.000 description 4
239000004327 boric acid Substances 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
229940124530 sulfonamide Drugs 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical class O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
HAYNOQKEKGEARS-UHFFFAOYSA-N 1h-azepine-2-sulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=CN1 HAYNOQKEKGEARS-UHFFFAOYSA-N 0.000 description 3
AWGBKZRMLNVLAF-UHFFFAOYSA-N 3,5-dibromo-n,2-dihydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=CC(Br)=C1O AWGBKZRMLNVLAF-UHFFFAOYSA-N 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
239000004743 Polypropylene Substances 0.000 description 3
239000007983 Tris buffer Substances 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
238000005415 bioluminescence Methods 0.000 description 3
230000029918 bioluminescence Effects 0.000 description 3
239000012888 bovine serum Substances 0.000 description 3
230000002860 competitive effect Effects 0.000 description 3
230000005923 long-lasting effect Effects 0.000 description 3
239000008055 phosphate buffer solution Substances 0.000 description 3
150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
229920001155 polypropylene Polymers 0.000 description 3
230000004044 response Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
102000040350 B family Human genes 0.000 description 2
108091072128 B family Proteins 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
108090001090 Lectins Chemical group 0.000 description 2
102000004856 Lectins Human genes 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
102000011923 Thyrotropin Human genes 0.000 description 2
108010061174 Thyrotropin Proteins 0.000 description 2
239000002250 absorbent Substances 0.000 description 2
230000002745 absorbent Effects 0.000 description 2
BDQRMEBGHYKVLA-UHFFFAOYSA-N acridine-1-sulfonamide Chemical compound C1=CC=C2C=C3C(S(=O)(=O)N)=CC=CC3=NC2=C1 BDQRMEBGHYKVLA-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
239000012876 carrier material Substances 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000002079 cooperative effect Effects 0.000 description 2
229920001577 copolymer Polymers 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 2
229910000071 diazene Inorganic materials 0.000 description 2
BTYPWVDULNVBHU-UHFFFAOYSA-N disodium;dinitrate Chemical compound [Na+].[Na+].[O-][N+]([O-])=O.[O-][N+]([O-])=O BTYPWVDULNVBHU-UHFFFAOYSA-N 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000011152 fibreglass Substances 0.000 description 2
125000005842 heteroatom Chemical group 0.000 description 2
230000000984 immunochemical effect Effects 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000002523 lectin Chemical group 0.000 description 2
238000004020 luminiscence type Methods 0.000 description 2
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
229920002554 vinyl polymer Polymers 0.000 description 2
BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
WDCYWAQPCXBPJA-UHFFFAOYSA-N 1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1 WDCYWAQPCXBPJA-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
DJIOGHZNVKFYHH-UHFFFAOYSA-N 2-hexadecylpyridine Chemical compound CCCCCCCCCCCCCCCCC1=CC=CC=N1 DJIOGHZNVKFYHH-UHFFFAOYSA-N 0.000 description 1
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
LFMLHZJVOZVZDK-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanamide;hexanoic acid Chemical compound CCCCCC(O)=O.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)N)SC[C@@H]21 LFMLHZJVOZVZDK-UFLZEWODSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
101710145634 Antigen 1 Proteins 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
229920000298 Cellophane Polymers 0.000 description 1
239000004380 Cholic acid Substances 0.000 description 1
108020004635 Complementary DNA Chemical group 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
229910052691 Erbium Inorganic materials 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
239000005909 Kieselgur Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
108010036176 Melitten Proteins 0.000 description 1
241000361919 Metaphire sieboldi Species 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
244000227633 Ocotea pretiosa Species 0.000 description 1
235000004263 Ocotea pretiosa Nutrition 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
XYIPYISRNJUPBA-UHFFFAOYSA-N [3-(3'-methoxyspiro[adamantane-2,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC(C3)CC2C4)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 XYIPYISRNJUPBA-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical class C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229920006318 anionic polymer Polymers 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000036436 anti-hiv Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
108010009043 arylesterase Proteins 0.000 description 1
102000028848 arylesterase Human genes 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
229910001570 bauxite Inorganic materials 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
XFLVBMBRLSCJAI-UHFFFAOYSA-N biotin amide Natural products N1C(=O)NC2C(CCCCC(=O)N)SCC21 XFLVBMBRLSCJAI-UHFFFAOYSA-N 0.000 description 1
239000012503 blood component Substances 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
235000019416 cholic acid Nutrition 0.000 description 1
229960002471 cholic acid Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
239000000306 component Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
101150000622 csrA gene Proteins 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
150000002012 dioxanes Chemical class 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000012636 effector Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000001378 electrochemiluminescence detection Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
239000004744 fabric Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000002309 gasification Methods 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000009434 installation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940029329 intrinsic factor Drugs 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
229910052743 krypton Inorganic materials 0.000 description 1
DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000003446 ligand Substances 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
239000003550 marker Substances 0.000 description 1
VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
238000012856 packing Methods 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000012071 phase Substances 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000193 polymethacrylate Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
239000000047 product Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000006862 quantum yield reaction Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical class O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
210000003625 skull Anatomy 0.000 description 1
239000004317 sodium nitrate Substances 0.000 description 1
235000010344 sodium nitrate Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000002689 soil Substances 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000008023 solidification Effects 0.000 description 1
125000003003 spiro group Chemical group 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
150000003456 sulfonamides Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229940098465 tincture Drugs 0.000 description 1
238000004448 titration Methods 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

TW080109188A 1990-11-09 1991-11-22 TW205095B (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US61123590A	1990-11-09	1990-11-09

Publications (1)

Publication Number	Publication Date
TW205095B true TW205095B (fr)	1993-05-01

Family

ID=24448191

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW080109188A TW205095B (fr)	1990-11-09	1991-11-22

Country Status (7)

Country	Link
EP (1)	EP0556331A4 (fr)
JP (1)	JPH06501559A (fr)
KR (1)	KR930702680A (fr)
AU (1)	AU650503B2 (fr)
CA (1)	CA2095825A1 (fr)
TW (1)	TW205095B (fr)
WO (1)	WO1992008979A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0774121A1 (fr) *	1994-07-15	1997-05-21	Abbott Laboratories	Amplification de signal chimioluminescent
US5705330A (en) *	1995-04-14	1998-01-06	Abbott Laboratories	Chemiluminescent immunoassay for antibody detection
US5858665A (en) *	1996-07-25	1999-01-12	Navix, Inc.	Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
DE69837155T2 (de) *	1997-09-22	2007-06-21	Novartis Vaccines and Diagnostics, Inc., Emeryville	Verfahren zum nachweiss von antikörpern in einer probe
AU9498098A (en)	1997-09-22	1999-04-12	Chiron Corporation	Buffers for stabilizing antigens
US6203974B1 (en) *	1998-09-03	2001-03-20	Abbott Laboratories	Chemiluminescent immunoassay for detection of antibodies to various viruses
JP4353793B2 (ja) *	2001-06-26	2009-10-28	アボット・ラボラトリーズ	Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法
US7101683B2 (en) *	2001-06-26	2006-09-05	Abbott Laboratories	Methods for the simultaneous detection of HCV antigens and HCV antibodies
US20110004085A1 (en)	2009-04-30	2011-01-06	Dexcom, Inc.	Performance reports associated with continuous sensor data from multiple analysis time periods
CN105181659A (zh)	2011-04-20	2015-12-23	万迈医疗仪器有限公司	发光聚合物循环扩增
CN111781345A (zh) *	2020-06-30	2020-10-16	上海透景生命科技股份有限公司	化学发光标记物标记抗原稳定剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228237A (en) *	1978-09-21	1980-10-14	Calbiochem-Behring Corp.	Methods for the detection and determination of ligands
FR2523311B1 (fr) *	1982-03-12	1985-12-27	Pasteur Institut	Produit de couplage entre une albumine et un ligand specifique, obtention et applications dans le domaine biologique
IL75020A (en) *	1984-05-10	1988-10-31	Abbott Lab	Biotin-antibiotin immunoassay for the detection of ligands
US4935339A (en) *	1985-05-07	1990-06-19	Nichols Institute Diagnostics	Delayed solid phase immunologic assay
US4927769A (en) *	1987-07-08	1990-05-22	Ciba Corning Diagnostics Corp.	Method for enhancement of chemiluminescence

1991
- 1991-11-08 WO PCT/US1991/008360 patent/WO1992008979A1/fr not_active Ceased
- 1991-11-08 CA CA002095825A patent/CA2095825A1/fr not_active Abandoned
- 1991-11-08 EP EP19920901340 patent/EP0556331A4/fr not_active Withdrawn
- 1991-11-08 KR KR1019930701366A patent/KR930702680A/ko not_active Withdrawn
- 1991-11-08 AU AU91049/91A patent/AU650503B2/en not_active Ceased
- 1991-11-08 JP JP4501517A patent/JPH06501559A/ja active Pending
- 1991-11-22 TW TW080109188A patent/TW205095B/zh active

Also Published As

Publication number	Publication date
JPH06501559A (ja)	1994-02-17
AU650503B2 (en)	1994-06-23
AU9104991A (en)	1992-06-11
EP0556331A1 (fr)	1993-08-25
EP0556331A4 (fr)	1994-10-12
WO1992008979A1 (fr)	1992-05-29
KR930702680A (ko)	1993-09-09
CA2095825A1 (fr)	1992-05-10

Publication	Publication Date	Title
CA2217818C (fr)	2010-10-26	Essai immunologique par chimiluminescence pour la detection d'anticorps
US4904583A (en)	1990-02-27	Cascade immunoassay by multiple binding reactions
US5332679A (en)	1994-07-26	Method for specific binding assays using a releasable ligand
JPH01227061A (ja)	1989-09-11	イオン捕捉イムノアッセイ法および装置
JPS59208463A (ja)	1984-11-26	ルミネツセント標識を含む固相イムノアツセイ法
TW205095B (fr)	1993-05-01
JP3363166B2 (ja)	2003-01-08	相互に対する極めて高い特異的親和性を有するペプチド対をイン・ビトロ診断分野に使用する方法
CN107589249B (zh)	2020-04-07	用于通过免疫复合物转移法检测被检物质的抗体试剂及其制造方法、以及该抗体试剂的用途
CA2193079C (fr)	2006-04-04	Procede de mise en oeuvre d'un dosage immunologique dans un systeme multiphase
IE69041B1 (en)	1996-08-07	Immunoassay on a preblocked solid surface
JPH04503865A (ja)	1992-07-09	カルジオリピン、フォスファチジルコリン及びコレステロールを固相に固定化する方法及びイムノアッセイ
JPH0677021B2 (ja)	1994-09-28	改良されたクラミジアアッセイ
KR101939891B1 (ko)	2019-01-17	당쇄를 포함하는 표적 물질의 검출용 시약, 검출 방법, 및 당쇄를 포함하는 표적 물질을 검출하기 위해서 이용되는 담체 및 그 제조 방법
EP0141620B1 (fr)	1991-10-23	Réactif pour essais à liaison spécifique
EP0338045A4 (en)	1990-12-05	Solid-phase non-separation enzyme assay
JPH04203968A (ja)	1992-07-24	化学発光免疫測定法
CA1309344C (fr)	1992-10-27	Dosage immunologique homogene a base de liposome pour epreuves diagnostiques
JP4068259B2 (ja)	2008-03-26	免疫測定方法及び乾式免疫測定試薬
US5460946A (en)	1995-10-24	Diagnostic test kit and specific binding assay using modulator of signal resulting from peroxidase label
WO1992016839A1 (fr)	1992-10-01	Dosage fluorometrique de chelate de lanthanide a resolution dans le temps
JPH02275360A (ja)	1990-11-09	酵素触媒作用の抑制による磁気イムノアッセイにおける信号の増強
JP2000292424A (ja)	2000-10-20	免疫測定方法
US20040214217A1 (en)	2004-10-28	Chemiluminescent compounds and use thereof
JPH09196922A (ja)	1997-07-31	複数の亜型が存在する抗原の共通抗原決定基に特異的な抗体の測定方法及び測定試薬